Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|November 7, 2025
Optimizing early-phase immunotherapy trials: the role of biomarker enrichment strategiesGreta Catani, Daniel Morchón-Araujo, Oriol Mirallas, et al.
International Journal of Molecular Sciences|June 13, 2025
Emerging Immunotherapy Targets in Early Drug DevelopmentDaniel Morchón-Araujo, Greta Catani, Oriol Mirallas, et al.
Translational Lung Cancer Research|May 22, 2026
Two-year treatment-free sustained remission after chemo-immunotherapy in a 52-year-old male with recurrent ARID1A-mutant lung adenocarcinoma: a case reportPedro Gonzalez Santa-Catalina, Daniel Morchón-Araujo, Marta Rodríguez-González, et al.
Translational Lung Cancer Research|August 13, 2025
Prognostic impact of negative TTF-1 biomarker in metastatic lung adenocarcinoma treated with chemo-immunotherapy: a retrospective cohort studyLuis Posado-Domínguez, Alejandro Olivares-Hernández, Daniel Morchón-Araujo, et al.
Frontiers in Oncology|January 22, 2026
Case Report: Mucoepidermoid carcinoma of the lung, a challenging diagnosis of an unusual caseMaría C Garijo Martínez, Alejandro Olivares-Hernández, Lorena Bellido Hernández, et al.
JHEP Reports : Innovation in Hepatology|May 1, 2026
Clinical features and management for CDK4/6 inhibitor-DILIMar Riveiro-Barciela, Paula Esteban, Kreina Sharela Vega-Cano, et al.
European Journal of Cancer (Oxford, England : 1990)|May 26, 2026
Association between chemotherapy use and prognosis in young patients with stage I-II ER+ /HER2-negative breast cancer according to Prosigna®: An international real-world analysis with propensity-score matchingGiuseppe Di Grazia, Vincenzo Di Lauro, Daniel Morchón-Araujo, et al.
Pageof 1